Can rabies be eradicated?

Developments in Biologicals

Volumn 131, Issue , 2008, Pages 95-122

  Rupprecht, Charles E ^a   Barrett, J ^b   Briggs, D ^c   Cliquet, F ^d   Fooks, A R ^e   Lumlertdacha, B ^f   Meslin, F X ^g   Muller T ^h   Nel, L H ⁱ   Schneider, C ^j   Tordo, N ^k   Wandeler, A I ^l  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b DEPARTMENT OF AGRICULTURE AND FISHERIES   (Australia)

^c KANSAS STATE UNIVERSITY   (United States)

^d Healthy Pigs Production and Experimentation Section   (France)

^e VETERINARY LABORATORIES AGENCY   (United Kingdom)

^f QUEEN SAOVABHA MEMORIAL INSTITUTE   (Thailand)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

ⁱ UNIVERSITY OF PRETORIA   (South Africa)

^j PAN AMERICAN HEALTH ORGANIZATION   (United States)

^k INSTITUT PASTEUR   (France)

^l CANADIAN FOOD INSPECTION AGENCY   (Canada)

more..

Author keywords

Animal control; Disease prevention; Dogs; Eradication; Lyssavirus; Rabies; Wildlife

Indexed keywords

RABIES VACCINE;

ANIMAL; ANIMAL DISEASE; CONFERENCE PAPER; DISEASE CARRIER; DISEASE TRANSMISSION; DOMESTIC ANIMAL; HEALTH SURVEY; HUMAN; PUBLIC HEALTH; RABIES; VIROLOGY; WILD ANIMAL; ZOONOSIS;

ANIMALS; ANIMALS, DOMESTIC; ANIMALS, WILD; DISEASE RESERVOIRS; HUMANS; POPULATION SURVEILLANCE; PUBLIC HEALTH; RABIES; RABIES VACCINES; ZOONOSES;

EID: 44649125440     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (111)

1. Tordo N, Benmansour A, Calisher C, Dietzgen RG, Fang RX, Jackson AO, Kurath G, Nadin-Davis S, Tesh RB, Walker PJ: Rhabdoviridae, in Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball A (eds): Virus Taxonomy, VIIIth Report of the ICTV. London, Elsevier/Academic Press, 2004, pp 623-644.
2. Badrane H, Bahloul C, Perrin P, Tordo N: Evidence of two lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol 2001;75:3268-3276.
3. Kuzmin IV, Hughes GJ, Botvinkin AD, Orciari LA, Rupprecht CE: Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res 2005;111:28-43.
4. Calisher CH, Childs JE, Field HE, Holmes KV, Schountz T: Bats: Important reservoir hosts of emerging viruses. Clin Microbiol Rev. 2006;19:531-545.
5. Smith JS, Orciari LA, Yager PA, Seidel HD, Warner CK: Epidemiologie and historical relationships among 97 rabies virus isolates as determined by limited sequence analysis. J Infect Dis 1992;166:296-307.
6. Velasco-Villa A, Orciari LA, Souza V, Juarez-Islas V, Gomez-Sierra M, Castillo A, Plisser A, Rupprecht CE: Molecular epizootiology of rabies associated with terrestrial carnivores in Mexico. Virus Res 2005;111:13-27.
7. Badrane H, Tordo N: Host-switching in lyssavirus history from chiroptera to carnivora orders. J Virol 2001;75:8096-8104.
8. Müller T, Cox J, Peter W, Schafer R, Johnson N, McElhinney LM, Geue JL, Tjornehoj K, Fooks AR: Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany. J Vet Med B Infect Dis Vet Public Health 2004;51:49-54.
9. Daoust PY, Wandeler AI, Casey GA: Cluster of rabies cases of probable bat origin among red foxes in Prince Edward Island, Canada. J Wildl Dis 1996;32:403-406.
10. Leslie MJ, Messenger S, Rohde RE, Smith J, Cheshier R, Hanlon C, Rupprecht CE. Bat-associated rabies virus in Skunks. Emerg Infect Dis 2006;12:1274-1277.
11. Vos A, Muller T, Neubert L, Zurbriggen A, Botteron C, Pohle D, Schoon H, Haas L, Jackson AC: Rabies in red foxes (Vulpes vulpes) experimentally infected with European bat lyssavirus type 1. J Vet Med B Infect Dis Vet Public Health 2004;51:327-332.
12. Dietzschold B, Schnell M, Koprowski H: Pathogenesis of rabies. Curr Top Microbiol Immunol 2005;292:45-56.
13. Almeida MF, Martorelli LF, Aires CC, Sallum PC, Massad E: Indirect oral immunization of captive vampires, Desmodus rotundus. Virus Res 2005;111:77-82.
14. Jallet C, Jacob Y, Bahloul C, Drings A, Desmezières E, Tordo N, Perrin P: Chimeric lyssavirus glycoproteins with increased immunological potential. J Virol 1999;73:225-233.
15. Taylor D: Rabies: epizootic aspects; diagnosis; vaccines; notes for guidance; official policy - epizootic aspects. Vet Rec 1976;99:157-160.
16. Wandeler AI: Oral immunization of wildlife, in Baer GM (ed.): The Natural History of Rabies. 2nd ed. Boca Raton, FL, CRC Press, 1991, pp 485-503.
17. Aubert M: Epidemiology of fox rabies, in: Bögel K, Meslin FX, Kaplan, M. (eds.): Wildlife Rabies Control. Wells Medical Ltd, 1992, pp 9-18.
18. Baer GM, Abelseth MK, Debbie JG: Oral vaccination of foxes against rabies. Am J Epidemiol 1971;93:487-490.
19. MacInnes CD, Smith SM, Tinline RR, Ayers NR, Bachmann P, Ball DG, Calder LA, Crosgrey SJ, Fielding C, Hauschildt P, Honig JM, Johnston DH, Lawson KF, Nunan CP, Pedde MA, Pond B, Stewart RB, Voigt DR: Elimination of rabies from red foxes in eastern Ontario. J Wildl Dis 2001;37:119-132.
20. Steck F, Wandeler AI, Bichsel P, Capt S, Schneider L: Oral immunisation of foxes against rabies. Zbl Vet Med B 1982;29:372-396.
21. Pastoret PP, Kappeier A, Aubert M: European rabies control and its history, in King AA, Fooks AR, Aubert M, Wandeler AI (eds). Historical Perspective of Rabies in Europe and the Mediterranean Basin. OIE, 2004, pp 337-347.
22. Müller WW: Rabies in Europe - Epidemiological cycles and impact of oral vaccination of foxes. Rabies Bulletin Europe 2000;24:8-12.
23. Cliquet F, Aubert M: Elimination of terrestrial rabies in Western European countries. Dev Biol (Basel). 2004;119:185-204.
24. Stöhr K, Meslin FM: Progress and setbacks in the oral immunisation of foxes against rabies in Europe. Vet Rec 1996;139:32-35.
25. Müller T, Schlüter H: Oral immunization of red foxes (Vulpes vulpes) against rabies - a review. J Etlik Vet Microbiol Ankara 1988;9:35-59.
26. Macpherson CNL, Meslin FX, Wandler AI (eds.): Dogs, Zoonoses and Public Health. Wallingford UK, CABI Publishing, 2000.
27. Wandeler AI, Budde A, Capt S, Kappeier A, Matter H: Dog ecology and dog rabies control. Rev Infect Dis 1988;10:S684-S688.
28. Wandeler AI, Matter HC, Kappeler A, Budde A: The ecology of dogs and canine rabies: a selective review. Revue Scientifique et Technique de l'Office International des Epizooties 1993;12:51-71.
29. Foggin CM: Rabies and rabies-related viruses in Zimbabwe: Historical, virological and ecological aspects. Doctor of Philosophy thesis, University of Zimbabwe, Harare, 1988.
30. Fekadu M: Canine rabies, in Baer GM (ed.): The Natural History of Rabies, 2nd Edition. Boca Raton, FL, CRC Press, 1991, pp 367-387.
31. Beran GW: Urban rabies, in Baer GM (ed.): The Natural History of Rabies, 2nd Edition. Boca Raton, FL, CRC Press, 1991, pp 427-443.
32. World Health Organization: WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies (WHO/EMC/ZOO.96.6). WHO, Geneva, 1997.
33. Acha PN, Arambulo III PV: Rabies in the Tropics - History and Current Status, in Kuwert E, Mérieux C, Koprowski H, Bögel K (eds.): Rabies in the Tropics. Berlin, Springer-Verlag, 1985, pp 343-359.
34. Eng TR, Fishbein HE, Talamante HE, Hall DB, Chavez GF, Dobbins JG, Muro FJ, Bustos JL, De Los Angeles Ricardt M, Munguia A, Carrasco J, Robles AR, Baer GM: Urban epizootic of rabies in Mexico: epidemiology and impact of animal bite injuries. Bull World Health Organ 1993;71:615-624.
35. Steck F, Wandeler AI: The epidemiology of fox rabies in Europe. Epidemiol Rev 1980;2:71-96.
36. Korns RF, Zeissig A: Dog, fox, and cattle rabies in New York State. Am J Public Health 1948;38:50-65.
37. Tierkel E, Groves L, Tuggle H, Wadley S: Effective control of an outbreak of rabies in Memphis and Shelby County, Tennessee. Am J Public Health 1950;40:1084-1088.
38. Fredrickson LE, Willett JC, Smith JE, Price ER: Mass immunisation of dogs against rabies. Its influence on a rabies epizootic in St.Louis. Am J Public Health 1953;43;399-404.
39. Wells CW: The control of rabies in Malaya through compulsory mass vaccination of dogs. Bull World Health Organ 1954;10:731-742.
40. World Health Organization: Guidelines for dog rabies control (VPH/83.43). WHO, Geneva, 1984.
41. World Health Organization /Food and Agriculture Organization: Guiding Principles for Planning, Organization and Management of Veterinary Public Health Programmes (ISS/WHO/FAO-CC/IZSTe/90.11). Rome, WHO/FAO, Collaborating Centre for Research and Training in Veterinary Public Health, 1990.
42. Frontini MG, Fishbein DB, Ramos JG, Coffins EF, Torres JMB, Huerta GQ, Rodriguez JDG, Belotto AJ, Dobbins JG, Linhart SB, Baer GM: A field evaluation in Mexico of four baits for oral rabies vaccination of dogs. Am J Trop Med Hyg 1992;47:310-316.
43. Matter HC: Oral immunization of dogs: analysis of dog populations and bait delivery systems, in Dodet B, Meslin FX (eds): Rabies Control in Asia. Amsterdam, Elsevier, 1997, pp 47-59.
44. Ben Youssef S, Matter HC, Schumacher CL, Kharmachi H, Jemli J, Mrabet L, Gharbi M, Hammami S, El Hicheri K, Aubert, MFA, Meslin FX: Field Evaluation of dog owner, participation-based, bait delivery system for the oral immunisation of dogs against rabies in Tunisia. Am J Trop Med Hyg 1988;58:835-845.
45. Chappuis G, Languet B, Duret C, Desmettre P: Dog rabies vaccination: The use of recombinant poxviruses by oral and parenteral route. Proceedings of the Symposium on Rabies Control in Asia, Jakarta, Indonesia 27-30 April 1993. Fondation Mérieux, Lyon, 1994, pp 125-138.
46. Fekadu M, Nesby SL, Shaddock JH, Schumacher CL, Linhart SB, Sanderlin DW: Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG 2) in dogs. Vaccine 1996;14:465-468.
47. Lembo T, Niezgoda M, Velasco-Villa A, Cleaveland S, Ernest E, Rupprecht CE: Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg Infect Dis 2006;12:310-313.
48. World Health Organization: WHO expert consultation on rabies, first report, WHO Technical Report Series 931, 2005, 121 pages.
49. Cliquet F, Barrat J: Rabies, in Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. World Organization for Animal Health, Fifth Edition, 2004, pp 328-346.
50. Tierkel ES: Rapid microscopic examination for Negri bodies and preparation of specimens for biological test, in Kaplan MM, Koprowski H (eds.): Laboratory Techniques in Rabies, Third edition. Geneva, World Health Organization, 1973, pp 41-50.
51. Miranda NLJ, Robles CG: A comparative evaluation of a new immunozymatic test (RREID) with currently used diagnostic tests (DME and FAT) for dog rabies. Southeast Asian J Trop Med Pub Hlth 1991;22:46-50.
52. Dean DJ, Abelseth MK: The fluorescent antibody test, in MM. Kaplan, H. Koprowski (eds): Laboratory Techniques in Rabies, Third edition. Geneva, Health Organization, 1973:74-78.
53. Webster WA, Casey GA, Charlton KM: The mouse inoculation test in rabies diagnosis: early diagnosis in mice during the incubation period. Can J Comp Med. 1976;40:322-325.
54. Webster WA: A tissue culture infection test in routine rabies diagnosis. Can J Vet Res 1987;51:367-369.
55. Wiktor TJ, Flamand A, Koprowski H: Use of monoclonal antibodies in diagnosis of rabies virus infection and differentiation of rabies and rabies-related viruses. J Virol Methods 1980;1:33-46.
56. Sacremento D, Bourhy H, Tordo N: PCR technique as an alternative method for diagnosis and molecular epidemiology of rabies virus. Mol Cell Probes 1991:5:229-240.
57. Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralising antibody. Bull World Health Organ 1973;5:902.
58. Cliquet F, Aubert M, Sagne L: Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods 1998;212:79-87.
59. Cliquet F, Verdier Y, Sagne L, Aubert M, Schereffer JL, Selve M, Wasniewski M, Serval A: Neutralising antibody titration in 25,000 sera of dogs and cats vaccinated against rabies in France, in the framework of the new regulations that offer an alternative to quarantine. Rev Sci Tech Off Int Epiz 2003;22:857-866.
60. Anonymous: Assessment of the risk of rabies introduction into the UK, Ireland, Sweden, Malta, as a consequence of abandoning the serological test measuring protective antibodies to rabies. EFSA Journal 2006:436:1-54.
61. Council of Europe: Rabies vaccine (live/oral for foxes (Monograph n0 0746). In the European Pharmacopoeia, Fifth Edition, Council of Europe, Strasbourg, 2005, France 792.
62. Aubert MFA, Blancou J: Potency test for inactivated rabies vaccine. II. NIH test in practice, in Kuwert E, Wiktor TJ, Koprowski H (eds.): Cell Culture Rabies Vaccines and their Protective Effect in Man. Geneva: International Green Group Cross, 1981, pp 259-268.
63. Council of Europe: Rabies Vaccine (inactivated) for Veterinary Use (Monograph no 0451). In the European Pharmacopoeia, Fourth Edition, Council of Europe, Strasbourg, 2002:2282-2284.
64. Baer GM: Evaluation of an animal rabies vaccine by use of two types of potency test. Am J Vet Res 1997;58:837-840.
65. Rooijakkers E, Groen J, Uittenbogarrd J, Van Herwijnen J, Osterhaus A: Development and evaluation of alternative testing methods for the in vivo NIH potency test used for quality control of inactivated rabies vaccines. Dev Biol Stand 1996:86:137-145.
66. Fournier-Curuana J, Porier B, Haond G, Jallet C, Fuchs F, Tordo N, et al: Inactivated rabies vaccine control and release: use of an ELISA method. Biologicals 2003;31:9-16.
67. Bruckner L, Cussler K, Halder M, Barrat J, Castle P, Duchow K, et al: Three Rs Approaches in the Quality Control of Inactivated Rabies Vaccines. Altern Lab Anim 2003;31:429-454.
68. Daas A, Milne C: Establishment of Batch 4 of the Biological Reference Preparation (BRP) for Rabies Vaccine (inactivated) for Veterinary Use. Rabies vaccine. Pharmeuropa Bio 2004;1:17-22.
69. Coetzee P, Nel LH: Emerging epidemic dog rabies in coastal South Africa: A molecular epidemiological analysis. Virus Res 2007;126:186-195.
70. Mallewa M, Fooks AR, Banda D, Chikungwa P, Mankhambo L, Molyneux E, Molyneux ME, Solomon T: Rabies encephalitis in malaria-endemic area, Malawi, Africa. Emerg Infect Dis 2007;13:136-139.
71. Haydon DT, Randall DA, Matthews L, Knobel DL, Tallents LA, Gravenor MB, Williams SD, Pollinger JP, Cleaveland S, Woolhouse ME, Sillero-Zubiri C, Marino J, Macdonald DW, Laurenson MK: Low-coverage vaccination strategies for the conservation of endangered species. Nature 2006;443:692-695. 72 Hofmeyr M, Bingham J, Lane EP, Ide A, Nel LH: Rabies in African wild dogs (Lycaon pictus) in the Madikwe Game Reserve, South Africa. Vet Rec 2000;146:50-52.
72. East ML, Hofer H, Cox JH, Wulle U, Wiik H, Pitra C: Regular exposure to rabies virus and lack of symptomatic disease in Serengeti spotted hyenas. Proc Natl Acad Sci USA 2001;98:15026-15031.
73. Mansfield KL, McElhinney LM, Hubschle O, Mettler F, Sabeta C, Nel LH, Fooks AR: A molecular epidemiological study of rabies epizootics in kudu (Tragelaphus strepsiceros) in Namibia. BMC Vet Res 2006;2:2.
74. Bingham J: Canine rabies ecology in southern Africa. Emerg Infect Dis 2005;11:1337-1342.
75. Sabeta CT, Mansfield KL, McElhinney LM, Fooks AR, Nel LH: Molecular epidemiology of rabies in bat-eared foxes (Otocyon megalotis) in South Africa. Virus Res 2007 Epub May 29.
76. Nel LH, Sabeta CT, von Teichman B, Jaftha JB, Rupprecht CE, Bingham J: Mongoose rabies in southern Africa: a re-evaluation based on molecular epidemiology. Virus Res 2005;109:165-173.
77. Nel LH: Vaccines for lyssaviruses other than rabies. Expert Rev Vaccines 2005;4:533-540.
78. Markotter W, Kuzmin I, Rupprecht CE, Randles J, Sabeta CT, Wandeler AI, Nel LH: Isolation of Lagos bat virus from water mongoose. Emerg Infect Dis 2006;12:1913-1918.
79. Paweska JT, Blumberg LH, Liebenberg C, Hewlett RH, Grobbelaar AA, Leman PA, Croft JE, Nel LH, Nutt L, S wanepoel R: Fatal human infection with rabies-related Duvenhage virus, South Africa. Emerg Infect Dis 2006;12:1965-1967.
80. Knobel DL, Cleaveland S, Coleman PG, Fevre EM, Meltzer MI, Miranda ME, Shaw A, Zinsstag J, Meslin FX: Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005;83:360-368.
81. Umeno S, Doi Y: A study of antirabic inoculation of dogs. Kitasato Arch Exp Med 1921;4:89.
82. Soon TY: Rabies in Malaysia. South East Asian J Trop Med Public Health 1988;19:535-536.
83. Zhang YZ, Xiong CL, Xiao DL, Jiang RJ, Wang ZX, Zhang LZ, Fu ZF: Human rabies in China. Emerg Infect Dis. 2005;11:1983-1984.
84. Windiyaningsih C, Wilde H, Meslin FX, Suroso T, Widarso HS: The rabies epidemic on Flores Island, Indonesia (1998-2003). J Med Assoc Thai 2004;87:1389-1393.
85. Puanghat A, Hunsoowan W: Rabies situation in Thailand. J Med Assoc Thai 2005;88:1319-1322.
86. Innoue S: Rabies contingency plan in Japan. Nippon Rinsho 2005;63:2180-2186.
87. AQIS: Australian Quarantine Inspection Service - Home page: Australian Government Department of Agriculture, Fisheries and Forestry 2007. http://www.daffa.gov.au/aqis
88. Pullar EM, McIntosh KS: The relationship of Australia to the world rabies problem. Aust Vet J 1954;30:326.
89. Barrett J: Australian bat lyssavirus. School of Veterinary Science, 2004. http://eprint.uq.edu.au/archive/00002417/01/barrett_thesis.pdf
90. Allworth A, Murray K, Morgan J: A human case of encephalitis due to a lyssavirus recently identified in fruit bats. Commun Dis Intell 1996;20:504.
91. Gould AR, Kattenbelt JA, Gumley SG, Lunt RA: Characterisation of an Australian bat lyssavirus variant isolated from an insectivorous bat. Virus Res 2002;89:1-28.
92. Hanna JN, Carney IK, Smith GA, Tannenberg AEG, Deverill JE, Botha JA, Serafin IL, Harrower BJ, Fitzpatrick PF, Searle JW: Australian bat lyssavirus infection: A second human case, with a long incubation period. Med J Aust 2000;172:597-599.
93. Warrilow D, Smith IL, Harrower B, Smith GA: Sequence analysis of an isolate from a fatal human infection of Australian bat lyssavirus. Virology 2002;297:109-119.
94. NHMRC: The Australian Immunisation Handbook, 8th Edition, Canberra: National Capital Printers, 2003. http://www9.health.gov.au/immhandbook/
95. Mackenzie SM, McLaughlin EA, Perkins HD, French N, Sutherland T, Jackson RJ, Inglis B, Muller WJ, van Leeuwen BH, Robinson AJ, Kerr PJ: Immunocontraceptive effects on female rabbits infected with recombinant myxoma virus expressing rabbit ZP2 or ZP3. Biol Reprod 2006;74:511-521.
96. Redwood AJ, Harvey NL, Lloyd M, Lawson MA, Hardy CM, Shellam GR: Viral vectored immunocontraception: Screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector. Vaccine 2007;25:698-708.
97. King AA, Fooks AR, Aubert M, Wandeler AI (eds.): Historical Perspective of Rabies in Europe and the Mediterranean Basin. OIE, Paris, 2004.
98. Organización Panamericana de la Salud: Estrategia y plan de acción para la eliminación de la rabia humana en América Latina para el final de la década 1980. Guayaquil, Ecuador, 1983.
99. Belotto A, Leanes LF, Schneider MC, Tamayo H, Correa, E: Overview of rabies in the Americas. Virus Res 2005;111:5-12.
100. Schneider C, et al: Situación epidemiológica de la rebia humana transmitida por perros en América Latina en 2004. Boletin Epidemiológico, Organización Panamericana de la Salud, 2005;26:2-4.
101. Organización Panamericana de la Salud: Sistema de vigilancia epidemiológica de la rabia en las Américas (SIRVERA), PANAFTOSA, Brasil, 2005. http://www.panaftosa.org.br
102. Schneider MC, Beiotto A, Ade MP, Hendrickx S, Leanes LF, Rodrigues MJ, Medina G, Correa E: Status of Dog Transmitted Human Rabies in Latin America. Cadernos de Saúde Pública, 2007.
103. Organización Panamericana de la Salud: Eliminación de la rabia humana transmitida por perro en América Latina: Análisis de la situación. Washington D.C., 2005. www.bvs.panaftosa.org.br/texto/OPS/ rabia-humana2004.pdf
104. Schneider MC, Burgoa CS: Algunas consideraciones sobre la rabia humana transmitida por murciélago. Revista de Salud Publica de México 1995;37:4.
105. Ross, RS, Wolters, B, Viazov, SO, Roggendorf M: Awareness of rabies risks and knowledge about preventive measures among experienced German travel health advisors. J Travel Med 2006;13:261-267.
106. Krebs JW, Long-Marin SC, Childs JE: Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States. J Public Health Manag Pract 1998;4:56-62.
107. Satapathy DM, Sahu T, Behera TR, Patnaik JK, Malini DS: Socio-clinical profile of rabies cases in anti-rabies clinic, M.K.C.G. Medical College, Orissa. Indian J Public Health 2005;49:241-242.
108. Rupprecht CE, Hanlon CA, Hemachuda T: Rabies re-examined. Lancet Infect Dis 2002;2:327-343.
109. Sriaroon C, Sriaroon P, Daviratanasilpa S, Khawplod P, Wilde H: Retrospective: animal attacks and rabies exposures in Thai children. Travel Med Infect Dis 2005;4:270-274.
110. Gibbons RV, Holman RC, Mosberg SR, Rupprecht CE: Knowledge of bat rabies and human exposure among United States cavers. Emerg Infect Dis 2002;8:532-535.
111. Cleaveland S, Kaare M, Knobel D, Laurenson MK: Canine vaccination-providing broader benefits for disease control. Vet Microbiol 2006;117:53-50.